Exploring Norbufotenine. To explore a different substance…

Names:
5-HO-NMT
Norbufotenine
N-Methylserotonin
5-Hydroxy-N-methyltryptamine
IUPAC name:
3-[2-(Methylamino)ethyl]-1H-indol-5-ol
5131 · C11H14N2O · 190.242
InChI=1S/C11H14N2O/c1-12-5-4-8-7-13-11-3-2-9(14)6-10(8)11/h2-3,6-7,12-14H,4-5H2,1H3
ASUSBMNYRHGZIG-UHFFFAOYSA-N This stereoisomer Any stereoisomer

Wurst, M; Kysilka, R; Flieger, M. Psychoactive tryptamines from Basidiomycetes. Folia Microbiol., 1 Feb 2002, 47 (1), 3–27. 3.1 MB. https://doi.org/10.1007/BF02818560

Peroutka, SJ; McCarthy, BG; Guan, X. 5-Benzyloxytryptamine: a relatively selective 5-hydroxytryptamine1D/1B agent. Life Sci., 1 Jan 1991, 49 (6), 409–418. 556 kB. https://doi.org/10.1016/0024-3205(91)90582-V

Barker, SA; Borjigin, J; Lomnicka, I; Strassman, R. LC/MS/MS analysis of the endogenous dimethyltryptamine hallucinogens, their precursors, and major metabolites in rat pineal gland microdialysate. Biomed. Chromatogr., 1 Dec 2013, 27 (12), 1690-1700. 929 kB. https://doi.org/10.1002/bmc.2981

Schmid, CL; Bohn, LM. Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a β-arrestin2/Src/Akt signaling complex in vivo. J. Neurosci., 6 Oct 2010, 30 (40), 13513–13524. 1.5 MB. https://doi.org/10.1523/JNEUROSCI.1665-10.2010

Halberstadt, AL; Geyer, MA. Effect of hallucinogens on unconditioned behavior. In Behavioral Neurobiology of Psychedelic Drugs; Halberstadt, AL; Vollenweider, FX; Nichols, DE, Eds., Springer, 1 Jan 2017; pp 159-199. 652 kB. https://doi.org/10.1007/7854_2016_466

N-HO-NMT
2-HO-NMT
4-HO-NMT
5-MeO-T
4-HO-α-MT
5-HO-α-MT
1-Me-5-HT
4-MeO-T
5245
6-HO-AMT
2-Methyl-5-HT · 2-Methylseroronin
HOT-T
4,4′-DMAR
3,4-DMAR · 3,4-Dimethylaminorex
10851
4-Ethylaminorex
10075
10074
10073
3,4-DMAR
4,4-DMAR
N,N-DMAR
BNZP
22 August 2018 · Creative Commons BY-NC-SA ·